MIT scientists have created a method to "paint" GLP-1 drugs onto antibodies inside the body, achieving longer-lasting effects ...

Sanofi’s treatment for hemophilia that can be administered as infrequently as once every other month, was approved by the US ...

CA$21.5m (loss widened by CA$18.6m from 3Q 2024). CA$0.66 loss per share (further deteriorated from CA$0.11 loss in 3Q 2024). AI is about to change healthcare. These 20 stocks are working on ...

In June 2024, the sNDA for TUOYI ® in combination with paclitaxel for injection (albumin-bound) for the first-line treatment ...

Today, the U.S. Food and Drug Administration approved Qfitlia (fitusiran) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of ...

The EMA has recommended refusing marketing authorization for donanemab, a monoclonal antibody against amyloid beta, in the ...

As of January 31st, 2025, we held $12.9 million in cash compared to $3.5 million at the fiscal year-end 2024. This increase was driven by the successful execution of our ATM program, through which we ...

The European Union’s CHMP said that the benefits of the drug, already approved in the U.S., do not outweigh the risk of ...

The home test, developed by privately held company Visby Medical, does not require mailing samples to a lab like other existing home-based STI tests. The new test for common STIs chlamydia, gonorrhea, ...

Checkpoint Therapeutics, Inc. ("Checkpoint") (Nasdaq: CKPT), a commercial-stage immunotherapy and targeted oncology company, today announced financial ...

A new discovery from Rutgers Health scientists could lead to better treatments for a deadly lung disease called Idiopathic ...

Spread the love Introduction The biotechnology industry continues to be at the forefront of scientific innovation, driving ...